Monosaccharides

Methyl D-arabinofuranoside is an antimycobacterial agent that inhibits the synthesis of mycolic acids, which are important components of the cell wall of Mycobacterium tuberculosis. Methyl D-arabinofuranoside has been shown to be active against drug-resistant strains and has been well tolerated by animals. This compound can be synthesized from 2,4-dichlorophenylacetic acid and arabinose in two steps. The first step involves a three-component condensation reaction with sodium hydroxide, hydrochloric acid, and 2,4-dichlorophenylacetic acid. The second step is a nucleophilic attack on the pyran ring of methyl D-arabinofuranoside with hypophosphorous acid. Methyl D-arabinofuranoside can also be prepared by reacting sodium nitrosobenzene with sodium benzene sulfinate in alcoholic solution

L-Idaric acid is a novel anti-inflammatory agent that is a derivative of the endogenous compound d-glucuronic acid. It has been shown to have anti-inflammatory effects in animal studies as well as in human cell cultures and it has been shown to be safe for use in humans. L-Idaric acid inhibits the production of inflammatory mediators, such as prostaglandins, leukotrienes, and cytokines. L-Idaric acid also inhibits the activity of β-glucuronidase, which may be responsible for its ability to prevent the degradation of glucuronic acid derivatives.

Penta-O-acetyl-a-L-idopyranose is a monosaccharide that is synthesized from D-glucose and acetic anhydride. It has been modified with methylation, fluorination, and saccharide modification. Penta-O-acetyl-a-L-idopyranose is soluble in water, methanol, ethanol, and acetone. This compound has been shown to be useful for glycosylation reactions as well as click chemistry. CAS No. 16299-15-3.

Allyl 2-acetamido-4,6,-O-benzylidene-2-deoxy-a-D-glucopyranoside is a sugar that is used as a custom synthesis or modification. It is also called allyl 2-(1,3-dioxo-1,3,4,-thiadiazolidinium)acetamido 4,6,-O-(benzylidene)-2 deoxy erythro -a D glucopyranoside. Allyl 2 acetamido 4,6,-O -benzylidene -2 deoxy erythro -a D glucopyranoside is used in the glycosylation of proteins and oligosaccharides and in the synthesis of saccharides. This compound has been shown to be useful in identifying glycosaminoglycan chains in complex carbohydrates.

4-Epi-daunosamine is a glycopeptide antibiotic that is used to treat infections caused by Gram-positive bacteria. It binds to the cell wall of these bacteria and inhibits the synthesis of new cell walls. This causes the cells to burst and die, which leads to bacterial death. 4-Epi-daunosamine has been shown to be effective against animal pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Clostridium perfringens. 4-Epi-daunosamine also has a low level of toxicity in humans, but can cause adverse effects such as nausea and vomiting if taken in large doses.

2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-serine pentafluorophenyl ester is a glycosylation agent that can be used in the synthesis of complex carbohydrates. It has been shown to react with various sugars and polysaccharides to form polymers. This chemical has also been used for the click modification of polymers and as a fluorinating agent in the synthesis of saccharides. 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl -N--Fmoc--L--serine pentafluorophenyl ester is soluble in water and organic solvents. It has been shown to be stable at high temperatures (up to 200°C) and is highly reactive.

D-glucose 6-phosphate is an intermediate in the hexose monophosphate shunt pathway. It is formed by the enzyme phosphoglucomutase from D-glucose 1-phosphate and UTP. D-glucose 6-phosphate is also an important intermediate in glycolysis. The conversion of D-glucose 6-phosphate to glucose 1,6-bisphosphate occurs through a series of reactions catalyzed by enzymes that are sensitive to inhibition by magnesium ions. These reactions include the phosphofructokinase, hexokinase, and pyruvate kinase reactions. The accumulation of glucose 6-phosphate leads to increased levels of lactate production and decreased levels of ATP production. This may be due to its ability to inhibit monoamine reuptake, which would lead to decreased synthesis of dopamine and serotonin.

D-[1-13C]Galacturonic acid potassium salt is a sugar that is synthesized by the reaction of galactose with carbon dioxide. This sugar has been custom synthesized and is used in glycosylation reactions. Other modifications to this sugar include methylation and click modification, which can be done to make the sugar more reactive. D-[1-13C]Galacturonic acid potassium salt is a high purity product with a CAS number.

1,2,3,6-Tetra-O-benzoyl-5-thio-D-glucopyranose is a monosaccharide that can be synthesized by the methylation of 1,2,3,6-tetra-O-(benzoyl) D-glucopyranose. The synthesis of this compound is accomplished by a click modification and the use of a fluoroquinolone to modify the sugar at C1. This compound has been shown to be an excellent substrate for polysaccharide and saccharide synthesis as well as fluorination. Purity levels are high with this product.

Glcnacβ(1-3)GalNAc-α-Thr is a polysaccharide that is found in the human body, which is a complex carbohydrate. It is an oligosaccharide modification of galactose and alpha-threonine. Glcnacβ(1-3)GalNAc-α-Thr can be custom synthesized to order with high purity and monosaccharide content. This product is used for research purposes and has not been approved for therapeutic use. The CAS number for this compound is 286959-52-2.

Phenyl a-L-thiorhamnopyranoside is a monosaccharide that is synthesized by the methylation of alpha-D-glucose. It is a custom synthesis that is used in the synthesis of oligosaccharides, polysaccharides, and sugar drugs. Phenyl a-L-thiorhamnopyranoside can be fluorinated to create an active form that has antibacterial activity. This compound has shown no signs of toxicity in animal studies and has been used as a food additive.

b-Core-APE-HSA is a custom synthesis of an oligosaccharide. This product is a complex carbohydrate with a CAS number and the molecular weight range of 500 to 10,000 Daltons. It is a polysaccharide that has been modified by methylation or glycosylation. The saccharide in this product is either glucose or mannose and it can be modified using click chemistry, fluorination, or other modifications. This product has high purity and can be synthesized using synthetic techniques such as glycosylation or Methylation.

Hesperetin 3'-O-beta-D-glucuronide is a glycosylate that is obtained by the glycosylation of hesperidin. Hesperetin 3'-O-beta-D-glucuronide is a sugar with a glycosylation site at the C3 position of the aglycone. It has shown to be an efficient inhibitor of Triglyceride Synthetase, which reduces triglycerides in the body. Hesperetin 3'-O-beta-D-glucuronide also has been shown to inhibit insulin release and increase insulin sensitivity in vitro.

Tert-Amyl 2-acetamido-2-deoxy-b-D-glucopyranoside is a synthetic derivative of the natural sugar nucleotide, UDP-N-acetylgalactosamine. It is a precursor for the synthesis of glycosaminoglycans, which are important components of proteoglycans and glycosaminoglycan aggregates. Tert-Amyl 2-acetamido-2-deoxy-b-D-glucopyranoside has been modified by fluorination and methylation to provide increased stability and reactivity. This product is available in high purity with a CAS number of 262849-66-1.

Iminosugar 2 is a custom synthesis that is modified with fluorination, methylation, and click modification. This product is a monosaccharide and an oligosaccharide that has glycosylation. It is a saccharide that has polysaccharides as complex carbohydrates. Iminosugar 2 can be used in the production of polymers and pharmaceuticals.

2-Deoxy-2-fluoro-L-[UL-13C]fucose is a modified sugar molecule used in various scientific applications, particularly in glycobiology and drug development.  It's used to study fucose-containing glycans, enzyme interactions, metabolic pathways, and glycoengineering. For instance, it can be incorporated into proteins to investigate the effects of fucose modifications on their function or used to develop drugs targeting fucose-metabolizing enzymes

MW of BSA approx 65000

Remdesivir impurity